News | Radiology Business | January 13, 2022

Human rights, employment, the environment and the fight against corruption are the pillars behind the 2030 Agenda and Esaote’s commitment to positioning its business within the multidisciplinary One Health approach

Franco Fontana, CEO of Esaote S.p.A.

Franco Fontana, CEO of Esaote S.p.A.


January 13, 2022 — The Board of Directors of Esaote, a leading Italian company in the biomedical sector – in ultrasound, dedicated magnetic resonance imaging (MRI) and information technology (IT) for healthcare – has decided to sign up to the United Nations Global Compact.

The United Nations Global Compact is the biggest global initiative dedicated to corporate citizenship and sustainability, created to encourage companies around the world to adopt a voluntary code with sustainable policies, to align their strategies with the universal principles on human rights, employment, environmental sustainability and the fight against corruption. The intention is to take action to promote the objectives of the United Nations, including the Sustainable Development Goals (2030 Agenda SDGs).

“For Esaote, the health of humans, animals and the ecosystem have always been inextricably linked. The decision to sign up to the Global Compact is in line with the ongoing transformative innovation strategy, the aim of which is to make our contribution effective and measurable using ESG metrics, in the areas of greatest impact for us,” stated Franco Fontana, CEO of Esaote S.p.A. “Promoting a culture of sustainability, enhancing human capital, ensuring health and safety in the workplace, increasing people's well-being, reducing environmental impact, investing in research and development for a sustainable, resilient and durable ecosystem: these are the pillars of the strategy Esaote is implementing for its development, which goes hand in hand with the multidisciplinary One Health approach aimed at reducing risks to health.”

A long-term strategy, on a journey that also includes the drafting of a sustainability report, the dissemination of socio-economic, ethical and environmental standards to suppliers and subsidiaries, the analysis and verification of value creation in the supply chain, all the way to the training of employees and business partners to ensure that an appropriate culture of ethics is in place.

For more information: www.esaote.com

Related Content

News | Digital Radiography (DR)

January 25, 2022 — Carestream Health was awarded 45 new patents in 2021 for global advances in artificial intelligence ...

Time January 26, 2022
arrow
News | Radiology Education

January 25, 2022 — Technical Prospects, a leader in the medical imaging industry, has announced the launch of its BioMed ...

Time January 25, 2022
arrow
News | Lung Imaging

January 25, 2022 — A new study based on data from a national cancer registry in Taiwan found evidence that lung cancer ...

Time January 25, 2022
arrow
Sponsored Content | Videos | Magnetic Resonance Imaging (MRI)

With the recent launch of the Magnifico Open, Italian company Esaote has entered the open MRI whole body space. ITN had ...

Time January 24, 2022
arrow
News | PACS

January 24, 2022 — Four organizations have selected Novarad, a leading healthcare technology company, as their PACS ...

Time January 24, 2022
arrow
News | Radiology Business

January 21, 2022 — IBM and Francisco Partners, a leading global investment firm that specializes in partnering with ...

Time January 21, 2022
arrow
News | Electronic Medical Records (EMR)

January 21, 2022 — StreamlineMD, a national leader in electronic health record (EHR) software and revenue cycle ...

Time January 21, 2022
arrow
News | Ultrasound Imaging

January 21, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), preoperative shear wave ...

Time January 21, 2022
arrow
Sponsored Content | Case Study | Computed Tomography (CT)

Approximately thirteen men out of every 100 will get prostate cancer during their lifetime, and about two to three men ...

Time January 21, 2022
arrow
News | Artificial Intelligence

January 20, 2022 — Leading health tech firm Qure.ai has gained 510(k) clearance from the Food and Drug Administration ...

Time January 20, 2022
arrow
Subscribe Now